Autor: |
Sunil Lakhwani, Alberto López‐Las Heras, Pablo Rodríguez‐García, Sandra Iraheta, Taida Martín‐Santos, María José Rodríguez‐Salazar, Patricia Machado, Miguel‐Teodoro Hernández |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
British journal of haematologyREFERENCES. |
ISSN: |
1365-2141 |
Popis: |
Intravenous Anti-Rhesus-D immunoglobulin (Anti-D) is a first-line treatment option for immune thrombocytopenia in non-splenectomised and RhD-positive patients. In this report, we retrospectively review our experience with intramuscular (IM) Anti-D treatment in 74 adult patients between 1990 and 2018. We found that 73% of patients showed a response; almost all of them had complete responses (68.89%), and 26% achieved complete responses sustained at least 6 months after treatment discontinuation. No significant side effects were observed with no cases of acute haemolysis or anaemia reported. We conclude from this study that IM Anti-D is an effective and safe treatment for immune thrombocytopenia. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|